Gut Bacteria Toxin Linked to Early-Onset Bowel Cancer

Researchers say the E. coli-produced toxin colibactin is a leading suspect in the rise of bowel cancer among younger adults.

Updated on Nov. 21, 2026 in Cancer

Photorealistic view of a glass petri dish holding a glowing amber bacterial colony on a steel laboratory bench, suggesting microbiology research.
Researchers told a UK parliamentary hearing on November 18, 2026, that the E. coli-produced toxin colibactin is a leading suspect in rising early-onset bowel cancer among adults under 40. AI Illustration. Upload story photo >

Live Poll

Do you take extra food safety precautions to protect your gut health?

Researchers have identified colibactin, a toxin produced by certain strains of Escherichia coli, as a leading suspect in the rise of early-onset bowel cancer. The findings were presented to a UK parliamentary hearing on November 18, 2026.

Why it matters

Colibactin can damage DNA, and the research points to a possible link between gut bacteria and cancers diagnosed in people under 40. Because colorectal cancer remains a major global health burden, identifying a potential cause could inform future prevention efforts.

A 2025 Nature analysis of 981 colorectal cancer genomes from 11 countries found colibactin-related DNA patterns in 169 of 802 tumors (21.1%), 3.3 times more common in people diagnosed before 40 than over 70. A November 2026 study of 638 individuals found colibactin-producing E. coli in 34.7% of patients versus 17.2% of controls, but the researchers have not established direct causation.

The players

World Health Organization (WHO)

The United Nations agency that coordinates international public health and publishes global disease burden estimates, including colorectal cancer and foodborne illness figures.

The details

Certain E. coli strains carry genes that enable them to produce colibactin, which damages the DNA of cells lining the intestine and may affect genes that control cell growth. Earlier mouse research showed the bacteria must attach to the intestinal lining to deliver this damage.

Timeline

  1. April 2025: Nature published the international colibactin DNA-pattern study.

  2. 2024: Mouse study showed E. coli must attach to deliver colibactin damage.

  3. November 2026: Cancer Causes & Control published a study linking colibactin E. coli to cancer patients.

  4. November 18, 2026: Researchers identified colibactin as a suspect at a UK parliamentary hearing.

Health Landscape

Approximately 1.9 million new colorectal cancer cases and more than 900,000 deaths were recorded worldwide in 2022, according to the WHO. The colibactin research adds a candidate microbial factor to the understanding of this burden, particularly among adults under 40 where incidence has been rising.

The findings are early and do not yet change screening or treatment recommendations for bowel cancer. Adults concerned about colorectal cancer risk should continue following established screening guidance from their clinicians.

The takeaway

Early-onset bowel cancer is an active area of research, and gut bacteria are now part of the investigation. Staying current with recommended screening is the most useful step for now.

Further reading

For more on how gut microbes and genetic damage relate to disease, explore our Cancer coverage.

Source note: This article includes information reported by Medindia.

Live Poll

Do you take extra food safety precautions to protect your gut health?